Table 2 Awareness and interest in genomic SNP testing for prostate cancer risk
From: Interest in genomic SNP testing for prostate cancer risk: a pilot survey
Item | PRAP group | Urology group | p |
|---|---|---|---|
N (%) | N (%) | ||
Awareness | Â | Â | Â |
Awareness of genomic SNP testing for PC risk | Â | Â | 0.38 |
  Not aware | 28 (70.0) | 34 (85.0) |  |
  A little | 4 (10.0) | 1 (2.5) |  |
  Somewhat | 4 (10.0) | 3 (7.5) |  |
  Quite | 2 (5.0) | 2 (5.0) |  |
  Very aware | 2 (5.0) | 0 (0.0) |  |
Awareness of genomic SNP tests on the Internet | Â | Â | Â |
  Not aware | 40 (100.0) | 38 (95.0) | 0.49 |
  Missing | 0 (0.0) | 2 (5.0) |  |
Interest | Â | Â | Â |
Interest in genomic SNP testing if standard-of-care | Â | Â | <0.001 |
  Strongly disagree | 0 (0.0) | 6 (15.0) |  |
  Sort of disagree | 0 (0.0) | 6 (15.0) |  |
  Neither agree nor disagree | 0 (0.0) | 4 (10.0) |  |
  Sort of agree | 10 (25.0) | 10 (25.0) |  |
  Strongly agree | 30 (75.0) | 14 (35.0) |  |
Interest change if ancestry markers revealed | Â | Â | 0.58 |
  No change | 20 (50.0) | 17 (42.5) |  |
  Maybe more interest | 12 (30.0) | 17 (42.5) |  |
  Definitely more interest | 8 (20.0) | 6 (15.0) |  |